- Home
- LSE vs CNTX Comparison
LSE vs CNTX Comparison
Compare LSE & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSE
- CNTX
- Stock Information
- Founded
- LSE 2007
- CNTX 2015
- Country
- LSE China
- CNTX United States
- Employees
- LSE N/A
- CNTX N/A
- Industry
- LSE Metal Fabrications
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- LSE Industrials
- CNTX Health Care
- Exchange
- LSE Nasdaq
- CNTX Nasdaq
- Market Cap
- LSE 85.6M
- CNTX 78.0M
- IPO Year
- LSE 2024
- CNTX 2021
- Fundamental
- Price
- LSE $5.56
- CNTX $0.68
- Analyst Decision
- LSE
- CNTX Strong Buy
- Analyst Count
- LSE 0
- CNTX 5
- Target Price
- LSE N/A
- CNTX $5.50
- AVG Volume (30 Days)
- LSE 29.1K
- CNTX 205.8K
- Earning Date
- LSE 01-01-0001
- CNTX 08-11-2025
- Dividend Yield
- LSE N/A
- CNTX N/A
- EPS Growth
- LSE N/A
- CNTX N/A
- EPS
- LSE 0.52
- CNTX N/A
- Revenue
- LSE $69,073,374.00
- CNTX N/A
- Revenue This Year
- LSE N/A
- CNTX N/A
- Revenue Next Year
- LSE N/A
- CNTX N/A
- P/E Ratio
- LSE $10.63
- CNTX N/A
- Revenue Growth
- LSE N/A
- CNTX N/A
- 52 Week Low
- LSE $3.76
- CNTX $0.49
- 52 Week High
- LSE $14.99
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- LSE N/A
- CNTX 39.96
- Support Level
- LSE N/A
- CNTX $0.82
- Resistance Level
- LSE N/A
- CNTX $0.84
- Average True Range (ATR)
- LSE 0.00
- CNTX 0.07
- MACD
- LSE 0.00
- CNTX -0.02
- Stochastic Oscillator
- LSE 0.00
- CNTX 1.45
About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares
Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment which supplies various equipments, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.